NCT02135315View on ClinicalTrials.gov

Intensive Arterial Pressure Control in Acute Coronary Syndrome

NACompletedINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Isosorbide Dinitrate

administration of continuous intravenous isosorbide dinitrate to obtain a SBP between 110 and 120 mmHg. After 2 hours from the start of treatment and if the blood pressure goal is not achieved, labetalol is used

Trial Locations (1)

5000

university of Monastir, Monastir

All Listed Sponsors
collaborator

Emergency NGO Onlus

OTHER

lead

University of Monastir

OTHER

NCT02135315 - Intensive Arterial Pressure Control in Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter